Journal
VIRUSES-BASEL
Volume 13, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/v13071390
Keywords
DNA damage; innate immunity; HPVs; epithelial differentiation; DAMPs
Categories
Ask authors/readers for more resources
Persistent infection with high-risk HPVs is a major risk factor for anogenital and oropharyngeal cancers. HPV replication depends on the activation of DNA damage repair pathways and evasion of immune surveillance. Targeting these processes with antiviral therapies may offer treatment opportunities for HPV-induced cancers.
Persistent infection with high-risk human papillomaviruses (HPVs) is the major risk factor associated with development of anogenital and oropharyngeal cancers. Initial infection by HPVs occurs into basal epithelial cells where viral genomes are established as nuclear episomes and persist until cleared by the immune response. Productive replication or amplification occurs upon differentiation and is dependent upon activation of the ataxia-telangiectasia mutated (ATM), ataxia telangiectasia and RAD3-related (ATR) DNA damage repair (DDR) pathways. In addition to activating DDR pathways, HPVs must escape innate immune surveillance mechanisms by antagonizing sensors, adaptors, interferons and antiviral gene expression. Both DDR and innate immune pathways are key host mechanisms that crosstalk with each other to maintain homeostasis of cells persistently infected with HPVs. Interestingly, it is still not fully understood why some HPV infections get cleared while others do not. Targeting of these two processes with antiviral therapies may provide opportunities for treatment of cancers caused by high-risk HPVs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available